{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"}],"units":"Participants"}],"description":"Measured by number of participants that have chimerism study results that show the number of donor cells and the number of recipient cells present in the blood after post-transplant lymphocyte infusions continue to be predominately either donor or recipient.","groups":[{"description":"Single Arm Intervention trial as noted in interventions section\n\nFludarabine: Fludarabine 30 mg/m2/day x 3 days\n\nTotal Body Irradiation: TBI 200cGy x1 dose on transplant day\n\nInfusion of Stem Cells: On Day 0 pts will received an infusion of HLA matched sibling donor stem cells. Dose is determined by the volume of cells obtained from donor. Minimum dose is 2x10\\*6 CD34+ cells per kilogram of recipient weight.","id":"OG000","title":"Single Arm Trial"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Post transplant up to 100 days post transplant","title":"Number of Participants With Detectable Donor Chimerism at up to 100 Days Post Transplant","type":"SECONDARY","unitOfMeasure":"participant"}